MGI Tech
Ares Genetics Collaborates With BGI on Coronavirus Testing in Europe
A subsidiary of Curetis, a firm recently merged with OpGen, Ares will use BGI technology to sequence samples in Europe.
BGI Sequencer, Coronavirus Molecular Assays Granted Emergency Use Approval in China
The DNBSEQ-T7 ultra-high-throughput sequencer, metagenomic sequencing kit for coronaviruses, and 2019-nCoV RT-qPCR kit have received authorization from China's NMPA.
MGI Receives CE Mark, Regulatory Clearance in Asia-Pacific Countries for Several Sequencers
The clearances pave the way to clinical applications for three of MGI's instruments but the BGI subsidiary faces legal challenges from Illumina in Europe and the US.
MGI Tech, Pillar Biosciences Sign Comarketing Agreement for NGS Panels
MGI Tech will market Pillar Biosciences' Onco/Reveal NGS panels alongside its high-throughput, automated library prep systems outside the US.
MGI Receives China FDA Registration for Sequencers
MGI received medical device certification clearance for its MGISEQ-200 and MGISEQ-2000 instruments.